ÂÜÀòÉç

Introduction

The 9th Annual Global Discovery To Development Innovation Forum (GDDIF) is the leading pharmaceutical R&D Summit for pharma decision makers, scientific leaders and solutions experts. 

Taking a truly holistic look at drug development today, GDDIF is dedicated to scientific insights, technology innovation & strategy across the entire therapeutic development lifecycle.

Themes

• Innovation within Screening, Enabling Technologies and Collaborative Partnerships
• Small Molecule Medicinal Chemistry: Strategies and Technologies​
• Enabling Collaborative Data Analysis
• Improving R&D Productivity & Data Quality
• Current trends in imaging technology
• Want, Find, Get, Manage – the key activities in exploiting the potential of partnerships
• Open-Access Collaboration in Accelerating Early Stage Drug Discovery
• Adopting the correct IT strategies for your business
• ​Integration and Mobility â€“ Why You Can’t Have One Without the Other 
• Interoperability â€“ Strategy, Tools and Information Governance

Deadlines

• Apr 18 2016
  Oral abstracts deadline

  
• Apr 18 2016
  Poster abstract deadline

  
• Apr 18 2016
  Standard registration deadline

  

Useful links

Speakers

• Stevan Djuric Senior Director, AbbVie, United Kingdom
• John Wise Executive Director, Pistoia Alliance, United Kingdom
• Mark O'Neil Johnson VP Analytical Chemistry, Sequoia Sciences, United Kingdom
• Craig Wegner Executive Director Translational Science, AstraZeneca, United Kingdom
• Wendy Hamilton Global Head Life Sciences, Thomson Reuters, United Kingdom
• Attila Berces Founder and Chairman, Omixon, United Kingdom
• Scott Thomas Director for Biology, Genetics, and Pharmacogenomics IT, United Kingdom
• Gyorgy Abel Director, Clinical Chemistry, Molecular Diagnostics, United Kingdom
• Aaron Sato Vice President of Research, Sutro Biopharma, United Kingdom
• Nikolaos Tezapsidis President & CEO, Neutrotez, United Kingdom
• Martin Moorhead Vice President of Computational Biology and Informatics, United Kingdom
• Qichao Zhu Principal Scientist, Boehringer Ingelheim, United Kingdom
• Satu Nakuhri Senior Scientist of Biomedical Informatics, Roche, United Kingdom
• James Brown Director Computational Biology, GSK, United Kingdom
• Maarten Leerkes Genome Analysis Specialist, Medical Science & Computing, United Kingdom
• Dongliang Ge Director of Bioinformatics, Gilead Sciences, United Kingdom
• Tim Hammonds Deputy Director of Discovery, Cancer Research, United Kingdom
• William Jai Chief Scientific Advisor, SIRC-TCM, United Kingdom
• Alastair Lawson Head of Antibody Biology, UCB, United Kingdom
• Michael Schneider Professor, National Heart & Lung Institute, Imperial College, United Kingdom
• Ted Torphy Chief Scientific Officer, BioMotiv, United Kingdom
• Michael Dabrowski CEO, Pelago Bioscience AB, United Kingdom
• Antonio Felici Senior Manager and Head of Microbiology, Aptuit Verona, United Kingdom
• Carl-Johan Ivarsson CEO, Qlucore, United Kingdom
• Harsukh Parmar SVP, Global Head of Research & Early Development Immunology, United Kingdom
• Werngard Czechtizky Head of Chemistry, Sanofi, United Kingdom
• Lee Babiss EVP Global Lab Services, PPD, United Kingdom
• Yike Guo Director at Data Science Institute, Imperial College London, United Kingdom
• Per I Arvidsson Executive Director Drug Discovery, Karolinska Institute, United Kingdom
• Jan Kriegl Director Computational Chemistry, Boehringer Ingelheim, United Kingdom
• Paul Denny-Gouldson VP Strategic Solutions, IDBS, United Kingdom
• Laurent Audoly Global Head R&D, Pierre Fabre, Duke-NUS Graduate Medical, United Kingdom
• Peter Hamley Global Head, External Innovation and Sourcing LGCR, Sanofi, United Kingdom
• Michael Rebhan Senior Investigator, Novartis, United Kingdom
• Robert Boland Directing Senior Manager, External Innovation R&D IT,, United Kingdom
• Steve Street VP and General Manager of Early Development,, United Kingdom
• Magadalena Tary-Lehmann Chief Scientific Officer, CTL, United Kingdom
• Khusru Asadullah Head of Global Biomarker, Bayer, United Kingdom
• Tim Hoctor Vice President, Life Science Solutions Services, Elsevier, United Kingdom
• Ron Newbold VP External Research and Development, Pfizer, United Kingdom
• Sándor Szalma Senior Research Fellow & Head of External Innovation R&D IT, United Kingdom
• Ratan Bhat Head of Strategy & Externalisation, Cardiovascular &, United Kingdom
• Magalie Rocheville External Engagement Lead, Advanced Manufacturing Technology, United Kingdom
• Arno Simon CEO, Beyontics, United Kingdom

---

Sponsorship & supporting organisations

---

Sponsors

Venue

Hilton Hotel Syon Park

Hilton Hotel Syon Park, Park Rd, Brentford, Middlesex , London, TW8 8JF, United Kingdom

Committee

• Stevan Djuric Senior Director, AbbVie, United Kingdom
• Jonathan Manson United Kingdom

---

Organised by

GBX Summits ® researches and produces some of the world's top premiership partnering summits in life sciences, outsourcing and manufacturing industries.

It is our goal to provide cutting-edge programmes that enable mindshare, accelerated learning and business collaboration.

It is our duty to deliver user-centric networking in order to endeavour pre-qualified one to one opportunities that facilitate tangible methods of return.

Contact information

Niklas Grobecker
GBXsummits
GBX SUMMITS LTD.
2nd Floor, 134 Tooley Street
London Bridge
London, SE1 2TU
United Kingdom
+44 (0) 207 089 4200
Contact us by email

---